Another stock that's trading within range of triggering a near-term breakout trade is Idenix Pharmaceuticals (IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, with operations in the U.S. and Europe.. This stock has been hammered by the bears during the last six months, with shares down by over 45%.
If you look at the chart for Idenix Pharmaceuticals, you'll see that this stock recently plunged big from around $11.12 to a low of $5.28 a share. During that sharp move lower, shares of IDIX saw high volume selloffs and it even gapped down large with big volume. That said, the stock has started to stabilize and trend sideways between $5.28 and $6.35 a share. A move outside of that sideways trading pattern soon will likely setup the next major trend for IDIX.
Market players should now look for long-biased trades in IDIX if it can manage to break out above some near-term overhead resistance levels at $6.16 to $6.35 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 2,088,730 shares. If that breakout triggers soon, then IDIX will have a great chance of re-filling its previous gap and possibly hitting $8 to $9.50 a share.One could look to buy IDIX off weakness and anticipate that breakout, and simply use a stop around some previous support levels at $5.50 to $5.28 a share. You could also just buy off strength once IDIX clears $6.16 to $6.35 with high volume, and simply use a stop at around $6 a share.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV